Similar articles

• Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.

  Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E. Devlin JW, et al. Crit Care Med. 2010 Feb;38(2):419-27. doi: 10.1097/CCM.0b013e3181b9e302. Crit Care Med. 2010. PMID: 19915454 Clinical Trial.
• Free your MIND and the rest will follow: decoding delirium in the intensive care unit.

  Balas MC. Balas MC. Crit Care Med. 2010 Feb;38(2):697-8. doi: 10.1097/CCM.0b013e3181c89542. Crit Care Med. 2010. PMID: 20083930 No abstract available.
• Neuroleptic malignant syndrome with use of quetiapine in mental retardation.

  Dan A, Bharadwaj R, Grover S. Dan A, et al. Psychiatry Clin Neurosci. 2009 Apr;63(2):255-6. doi: 10.1111/j.1440-1819.2008.01921.x. Psychiatry Clin Neurosci. 2009. PMID: 19335404 No abstract available.
• Treatment of delirium in the critically ill patient.

  Fish DN. Fish DN. Clin Pharm. 1991 Jun;10(6):456-66. Clin Pharm. 1991. PMID: 1676622 Review.
• Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.

  Rea RS, Battistone S, Fong JJ, Devlin JW. Rea RS, et al. Pharmacotherapy. 2007 Apr;27(4):588-94. doi: 10.1592/phco.27.4.588. Pharmacotherapy. 2007. PMID: 17381385 Review.